Heparin sodium and Requip drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Heparin sodium (heparin sodium) and Requip (ropinirole hydrochloride). Common drug interactions include drug ineffective among females and dyspnoea among males.
The phase IV clinical study analyzes what interactions people have when they take Heparin sodium and Requip. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.
What is Heparin sodium?
Heparin sodium has active ingredients of heparin sodium. It is often used in deep venous thrombosis. eHealthMe is studying from 21,065 Heparin sodium users. Check the latest studies of Heparin sodium.
What is Requip?
Requip has active ingredients of ropinirole hydrochloride. It is often used in restless leg syndrome. eHealthMe is studying from 22,950 Requip users. Check the latest studies of Requip.
21 people who take Heparin sodium and Requip together, and have interactions are studied.

What are the common drug interactions of Heparin Sodium and Requip, by gender? *:
female:
- Drug ineffective
- Euphoric mood (excessively happy but may become angry or irritable)
- Haemorrhage (bleeding)
- Nausea (feeling of having an urge to vomit)
- Palpitations (feelings or sensations that your heart is pounding or racing)
- Peripheral swelling
- Skin disorder (skin disease)
- Therapeutic response unexpected
- Thermal burn (burn by heat)
- Tremor (trembling or shaking movements in one or more parts of your body)
male:
- Dyspnoea (difficult or laboured respiration)
- Feeling hot
- Flushing (the warm, red condition of human skin)
- Hyperhidrosis (abnormally increased sweating)
- Hypotension (abnormally low blood pressure)
- Nausea (feeling of having an urge to vomit)
- Thirst
- Inguinal hernia, obstructive (hernia in which a loop of intestine enters the inguinal canal cause obstruction)
What are the common drug interactions of Heparin Sodium and Requip, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Atrial flutter (an abnormal heart rhythm that occurs in the atria of the heart)
- Blood creatinine increased
- Cardiac arrest
- Cardiac ventricular disorder (ventricular dysfunction of heart)
- Conduction disorder (serious disorder of the heart not responses proper to impulses)
- Constipation
- Culture urine positive
- Diarrhoea
- Dyspnoea (difficult or laboured respiration)
- Electrocardiogram st-t change
50-59:
- Abdominal pain
- Diarrhoea
- Malaise (a feeling of general discomfort or uneasiness)
- Blood pressure decreased
- Death
- Dyspnoea (difficult or laboured respiration)
- Hyperhidrosis (abnormally increased sweating)
- Nausea (feeling of having an urge to vomit)
- Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs)
- Anaemia (lack of blood)
60+:
- Nausea (feeling of having an urge to vomit)
- Dyspnoea (difficult or laboured respiration)
- Cerebral infarction (less blood supply to brain resulting tissue damage)
- Headache (pain in head)
- Muscle spasms (muscle contraction)
- Pharyngolaryngeal pain
- Rash
- Stomach discomfort (pain in abdomen)
- Subarachnoid haemorrhage (blood leaks into the space between two membranes that surround the brain)
- Feeling hot
What are the existing conditions these people have? *
- Pain: 9 people, 42.86%
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 6 people, 28.57%
- Cataplexy (loss of muscle tone accompanied by full conscious awareness): 6 people, 28.57%
- Depression: 5 people, 23.81%
- Hyperparathyroidism Secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary): 4 people, 19.05%
- Neuropathy Peripheral (surface nerve damage): 4 people, 19.05%
- Anaemia (lack of blood): 4 people, 19.05%
- Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood): 4 people, 19.05%
- Insomnia (sleeplessness): 3 people, 14.29%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 14.29%
* Approximation only. Some reports may have incomplete information.
Do you take Heparin sodium and Requip?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Heparin sodium (21,065 reports)
- Requip (22,950 reports)
Browse all drug interactions of Heparin sodium and Requip:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Heparin sodium:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Requip:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Heparin sodium and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Requip and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on heparin sodium and ropinirole hydrochloride (the active ingredients of Heparin sodium and Requip, respectively), and Heparin sodium and Requip (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Mitoxantrone Hydrochloride and Caspofungin Acetate - 6 seconds ago
- Metformin Hydrochloride and Joint Injury for Women aged 50-59 - 17 seconds ago
- Could Evening Primrose cause Tumor? - 18 seconds ago
- Asthma in Centrum Silver, how severe and when it was recovered? - 20 seconds ago
- Drug interactions of Iloperidone and Clonidine - 25 seconds ago
- Magnesium Glycerophosphate and Codeine drug interactions for women aged 60+ - 26 seconds ago
- Could Vitamin D cause Tumor Lysis Syndrome? - 32 seconds ago
- Drug interactions of Toradol and Levaquin - 32 seconds ago
- Sodium Chloride and Sweating - Excessive for Women aged 30-39 - 45 seconds ago
- Sodium Chloride and Perspiration - Excessive for Women aged 30-39 - 45 seconds ago